featured
Tralokinumab With Topical Corticosteroids for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tralokinumab Plus Topical Corticosteroids for the Treatment of Moderate-to-Severe Atopic Dermatitis: Results From the Double-Blind, Randomized, Multicentre, Placebo-Controlled Phase III ECZTRA 3 Trial
Br J Dermatol 2021 Mar 01;184(3)450-463, JI Silverberg, D Toth, T Bieber, AF Alexis, BE Elewski, AE Pink, D Hijnen, TN Jensen, B Bang, CK Olsen, A Kurbasic, S Weidinger, ECZTRA 3 study investigatorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.